Align Technology Market Cap 2006-2018 | ALGN
Historical market capitalization for Align Technology (ALGN) over the last 10 years. The current market cap for Align Technology (ALGN) as of March 31, 2018 is $29.68B.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $0.027B | $1.473B |
| Align Technology, Inc. is a global medical device company with industry-leading innovative products such as Invisalign clear aligners, iTero Intraoral scanners, and OrthoCAD digital services that help dental professionals achieve the clinical results they expect and deliver effective, cutting-edge dental options to their patients. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Becton, Dickinson (BDX) | United States | $65.994B | 24.72 |
| McKesson (MCK) | United States | $27.000B | 10.59 |
| Laboratory Of America Holdings (LH) | United States | $19.054B | 18.41 |
| AmerisourceBergen (ABC) | United States | $18.806B | 13.69 |
| Cardinal Health (CAH) | United States | $15.224B | 9.61 |
| Cooper (COO) | United States | $12.177B | 22.67 |
| Henry Schein (HSIC) | United States | $11.518B | 20.40 |
| DENTSPLY SIRONA (XRAY) | United States | $10.312B | 17.31 |
| West Pharmaceutical Services (WST) | United States | $7.319B | 40.77 |
| Merit Medical Systems (MMSI) | United States | $2.821B | 42.39 |
| Patterson (PDCO) | United States | $2.177B | 13.68 |
| CONMED (CNMD) | United States | $2.068B | 35.98 |
| STAAR Surgical (STAA) | United States | $1.411B | 484.29 |
| Atrion (ATRI) | United States | $1.169B | 33.39 |
| Invacare (IVC) | United States | $0.713B | 0.00 |
| Endologix (ELGX) | United States | $0.449B | 0.00 |
| Antares Pharma (ATRS) | United States | $0.433B | 0.00 |
| Lifevantage (LFVN) | United States | $0.148B | 30.68 |
| Aceto (ACET) | United States | $0.101B | 4.10 |
| Milestone Scientific (MLSS) | United States | $0.029B | 0.00 |
| Pro-Dex (PDEX) | United States | $0.029B | 12.98 |
| Retractable Technologies (RVP) | United States | $0.027B | 0.00 |
| Biolase (BIOL) | United States | $0.027B | 0.00 |
